WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes announced a patient initiative to support American Diabetes Association Alert Day® which is March 27, 2012. The Company has initiated a program to expand awareness of diabetic peripheral neuropathy (DPN) which affects over 50% of people with diabetes and can lead to foot ulcers and amputation. Under the program, the Company’s customers can select from a range of patient outreach materials that provide educational content regarding DPN and the importance of annual foot examinations for patients with diabetes.
